Antipsychotics Agents
Mostrando 1-12 de 15 artigos, teses e dissertações.
-
1. Use of psychiatric drugs in Dermatology,
Abstract Patients with psychocutaneous disorders often refuse psychiatric intervention in their first consultations, leaving initial management to the dermatologist. The use of psychotropic agents in dermatological practice, represented by antidepressants, antipsychotics, anxiolytics, and mood stabilizers, should be indicated so that patients receive the mos
An. Bras. Dermatol.. Publicado em: 2020-03
-
2. Entre polêmicas abertas e veladas
Abstract Patients with psychocutaneous disorders often refuse psychiatric intervention in their first consultations, leaving initial management to the dermatologist. The use of psychotropic agents in dermatological practice, represented by antidepressants, antipsychotics, anxiolytics, and mood stabilizers, should be indicated so that patients receive the mos
Bakhtiniana, Rev. Estud. Discurso. Publicado em: 2020-03
-
3. Prevalence of and factors associated with antipsychotic polypharmacy in patients with serious mental illness: Findings from a cross-sectional study in an upper-middle-income country
Objective: The aim of our study was to examine the prevalence of and factors associated with antipsychotic polypharmacy (APP) among patients with serious mental illness in the current South African health care context. Methods: We collected data on patient, illness, and treatment characteristics of patients discharged on one or more antipsychotic agents fr
Rev. Bras. Psiquiatr.. Publicado em: 06/02/2017
-
4. Use of psychotropic medications during pregnancy: perception of teratogenic risk among physicians in two Latin American countries
Objective: Pregnant women and their health care professionals commonly believe that use of medications during pregnancy may be harmful to the unborn fetus. The objective of this study was to evaluate the risk perception of psychotropic drug use in pregnancy among physicians in different medical specialties. Method: This was a convenience survey conducted
Rev. Bras. Psiquiatr.. Publicado em: 24/03/2014
-
5. Increased dyslipidemia in schizophrenic outpatients using new generation antipsychotics / Dislipidemia aumentada em pacientes esquizofrênicos ambulatoriais em uso de antipsicóticos de nova geração / Dislipidemia aumentada em pacientes esquizofrênicos ambulatoriais em uso de antipsicóticos de nova geração
Objetivo: Antipsicóticos de primeira e de segunda geração estão implicados em alterações metabólicas. Foi elaborado este estudo transversal para verificar se os antipsicóticos de segunda geração estavam associados a maiores níveis de glicose e lipídeos, independente de idade e sexo, em pacientes atendidos no Programa de Esquizofrenia e Demência
Publicado em: 2010
-
6. Eficácia de antipsicóticos atípicos comparados à clozapina em pacientes com esquizofrenia refratária: revisão sistemática e metanálise / Efficacy of atypical antipsychotics versus clozapine in patients with refractory schizophrenia: systematic review and meta-analysis
INTRODUÇÃO: Considera-se a clozapina como padrão-ouro para o tratamento de pacientes com esquizofrenia refratária, com base principalmente em sua eficácia comprovadamente superior em relação aos antipsicóticos típicos. No entanto, os dados acerca do uso de outros antipsicóticos atípicos ainda são escassos ou divergentes. Tendo em vista que o uso
Publicado em: 2010
-
7. A double-blind comparison of the effect of the antipsychotics haloperidol and olanzapine on sleep in mania
The effects of haloperidol and olanzapine on polysomnographic measures made in bipolar patients during manic episodes were compared. Twelve DSM-IV mania patients were randomly assigned to receive either haloperidol (mean ± SD final dosage: 5.8 ± 3.8 mg) or olanzapine (mean ± SD final dosage: 13.6 ± 6.9 mg) in a 6-week, double-blind, randomized, controlle
Brazilian Journal of Medical and Biological Research. Publicado em: 02/02/2006
-
8. "Perfil demográfico e clínico de pessoas que fazem uso de decanoato de haloperidol " / "Demographic and clinic profile of people who use Haloperidol Decanoate"
No adherence to pharmacological treatment is a determinant factor in the severity of chronic illnesses and is closely related to relapses. Indicated as option of better control the adhesion and fallen again prevention, Haloperidol Decanoate by itself does not guarantee the success of the treatment. The objective was to describe demographic and clinical chara
Publicado em: 2006
-
9. Alcool e drogas na esquizofrenia
The aim of this investigation was to evaluate drug and alcohol use in schizophrenia through a comparative, case-control study of two groups of age and sex matched schizophrenics who fulfilled the DSMIV criteria for schizophrenia. The case group consisted of individuals with a previous history of alcohol use, at least, in the past month, and a history of drug
Publicado em: 2000
-
10. Atypical Antipsychotic Use in the Treatment of Psychosis in Primary Care
Atypical antipsychotics are a class of novel agents increasingly employed for the treatment of psychotic disorders. The pharmacodynamic properties of the atypicals appear to impact a broader spectrum of psychotic symptoms than had been appreciated with older generation antipsychotics. In addition, the atypical agents appear to have a reduced risk of neurolog
Physicians Postgraduate Press.
-
11. Interventions for Weight Gain in Adults Treated With Novel Antipsychotics
Background: Weight gain is a significant side effect associated with typical and atypical antipsychotic agents. It has the potential to add to the increased morbidity and mortality associated with schizophrenia and schizoaffective disorder. Because the newer antipsychotic medications have proved to be superior to traditional agents in controlling the positiv
Physicians Postgraduate Press.
-
12. Recognizing and Managing Antipsychotic Drug Treatment Side Effects in the Elderly
Although atypical antipsychotics differ from conventional antipsychotics in their decreased ability to cause reversible drug-induced movement disorders/motor side effects such as dystonia, drug-induced parkinsonism, and akathisia and potentially persistent drug-induced movement disorders/motor side effects such as tardive dyskinesia, no antipsychotic agent c
Physicians Postgraduate Press.